CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)
Conditions: Non-hodgkin Lymphoma; Acute Lymphoblastic Leukemia Interventions: Biological: CD19.CAR-multiVST for Group A; Biological: CD19.CAR-multiVST for Group B Sponsors: Baylor College of Medicine; Texas Children's Hospital; The Methodist Hospital System; Center for Cell and Gene Therapy, Baylor College of Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Baylor College of Medicine | Children | Gene Therapy | Genetics | Hospitals | Leukemia | Lymphoma | Research